Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts
Listen as experts discuss current best practices and emerging approaches for treating patients with myelofibrosis.
Decera Clinical Education Oncology Podcast
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, John Mascarenhas, MD, and Ruben A. Mesa, MD, FACP, discuss current best practices and emerging approaches for treating patients with myelofibrosis, including:
- Overall approach to treatment
- Use of JAK inhibitors for treating myelofibrosis
- Treating patients with low platelets
- Defining JAK inhibitor failure
- Unmet needs in treatment and emerging therapeutic options, including momelotinib, luspatercept, ruxolitinib add-on therapy, and other phase III approaches
Presenters:
John Mascarenhas, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai
Director, Adult Leukemia Program
Leader, Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute
New York, New York
Ruben A. Mesa, MD, FACP
Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Enterprise Senior Vice President, Atrium Health
President, Enterprise Cancer Service Line
Vice Dean for Cancer Programs, Wake Forest University School of Medicine
Professor of Medicine, Wake Forest University School of Medicine
Winston-Salem, North Carolina
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.